US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BlackRock 2037 Municipal Target Term

23.85

+0.05000.21%

Volume:9K

Turnover:206.77K

Market Cap:146.62M

PE:36.69

High:24.10

Open:24.10

Low:23.84

Close:23.80

52wk High:27.96

52wk Low:23.79

Shares:6.15M

Float Shares:6.15M

Volume Ratio:1.49

T/O Rate:0.14%

Dividend:1.13

Dividend Rate:4.72%

EPS(TTM):0.6500

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Bannerman Energy Seeks ASX Quotation for Additional BMN Shares

BioMarin Pharmaceutical Presents 3-Year Voxzogo Data, Early BMN 333 Results for Growth Disorder Treatments

MT Newswires Live

BioMarin’s Voxzogo and BMN 333 show impact in hypochondroplasia, achondroplasia

We're Hopeful That Bannerman Energy (ASX:BMN) Will Use Its Cash Wisely

Simply Wall St.

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

THOMSON REUTERS

BioMarin's ENPP1 Deficiency Phase 3 Trial Falls Short, BMN 401 Fails to Meet Clinical Benefit Endpoint

BioMarin Pharmaceutical Reports No Functional Improvement in BMN 401 ENPP1 Deficiency Study

MT Newswires Live

BioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial

BioMarin Extends BMN 351 Duchenne Study, Keeping Long-Term Data in Focus for Investors

BioMarin’s BMN 333 Takes On Vosoritide in High Stakes Achondroplasia Trial

Controversy Surrounds BGN Procurement for MBG Project, From Motorbikes to EO Services

Bannerman Energy Ltd (ASX:BMN) Is Expected To Breakeven In The Near Future

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BMN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMN\",,,,,undefined,":{"symbol":"BMN","market":"US","secType":"STK","nameCN":"BlackRock 2037 Municipal Target Term","latestPrice":23.8499,"timestamp":1789660862929,"preClose":23.7999,"halted":0,"volume":8629,"delay":0,"changeRate":0.002100849163231808,"floatShares":6147653,"shares":6147653,"eps":0.65,"marketStatus":"Trading","change":0.05,"latestTime":"09-17 12:01:28 EDT","open":24.095,"high":24.095,"low":23.835,"amount":206768.149774,"amplitude":0.010924,"askPrice":24.37,"askSize":200,"bidPrice":23.85,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.65,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"listingDate":1666843200000,"exchange":"NYSE","adjPreClose":23.7999,"dividendRate":0.047183,"postHourTrading":{"tag":"盘后","latestPrice":23.7999,"preClose":23.7999,"latestTime":"19:30 EDT","volume":84,"amount":1999.1994,"timestamp":1789601404437,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.492289},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMN\",,,,,undefined,":{"symbol":"BMN","floatShares":6147653,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.492289,"shares":6147653,"dividePrice":1.1253,"high":24.095,"amplitude":0.010924,"preClose":23.7999,"low":23.835,"week52Low":23.79,"pbRate":"--","week52High":27.96,"institutionHeld":0,"latestPrice":23.8499,"committee":0.666667,"eps":0.65,"divideRate":0.047183,"volume":8629,"delay":0,"ttmEps":0.65,"open":24.095,"prevYearClose":26.18,"prevWeekClose":24.6051,"prevMonthClose":25.91,"prevQuarterClose":25.7,"fiveDayClose":24.55,"twentyDayClose":25.75,"sixtyDayClose":25.5886},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMN\",params:#limit:5,,,undefined,":[{"date":"2026-12-11","symbol":"BMN","amount":0.09925,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-12-11","defaultRemindTime":1796999400000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-12-22","payableDate":"2026-12-11","currency":"USD","dateTimestamp":1796965200000,"payDate":"2026-12-22"},{"date":"2026-11-13","symbol":"BMN","amount":0.09925,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-11-13","defaultRemindTime":1794580200000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-12-01","payableDate":"2026-11-13","currency":"USD","dateTimestamp":1794546000000,"payDate":"2026-12-01"},{"date":"2026-10-15","symbol":"BMN","amount":0.09925,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-15","defaultRemindTime":1792071000000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-11-02","payableDate":"2026-10-15","currency":"USD","dateTimestamp":1792036800000,"payDate":"2026-11-02"},{"date":"2026-09-15","symbol":"BMN","amount":0.09375,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-01","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-10-01"},{"date":"2026-08-14","symbol":"BMN","amount":0.09375,"announcedDate":"2026-06-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-14","defaultRemindTime":1786714200000,"name":"BlackRock 2037 Municipal Target Term","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-01","payableDate":"2026-08-14","currency":"USD","dateTimestamp":1786680000000,"payDate":"2026-09-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMN\",market:\"US\",,,undefined,":[{"executeDate":"2023-01-12","recordDate":"2023-01-13","paymentDate":"2023-02-01","value":0.09375,"currency":"USD"},{"executeDate":"2023-02-14","recordDate":"2023-02-15","paymentDate":"2023-03-01","value":0.09375,"currency":"USD"},{"executeDate":"2023-03-14","recordDate":"2023-03-15","paymentDate":"2023-04-03","value":0.09375,"currency":"USD"},{"executeDate":"2023-04-13","recordDate":"2023-04-14","paymentDate":"2023-05-01","value":0.09375,"currency":"USD"},{"executeDate":"2023-05-12","recordDate":"2023-05-15","paymentDate":"2023-06-01","value":0.09375,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648572260","title":"Bannerman Energy Seeks ASX Quotation for Additional BMN Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648572260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648572260?lang=en_us&edition=fundamental","pubTime":"2026-07-02 15:08","pubTimestamp":1782976089,"startTime":"0","endTime":"0","summary":"Bannerman Energy ( ($AU:BMN) ) just unveiled an announcement. Bannerman Energy has applied for quotation of additional ordinary fully paid shares o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bannerman-energy-seeks-asx-quotation-for-additional-bmn-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bannerman-energy-seeks-asx-quotation-for-additional-bmn-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643234768","title":"BioMarin Pharmaceutical Presents 3-Year Voxzogo Data, Early BMN 333 Results for Growth Disorder Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2643234768","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643234768?lang=en_us&edition=fundamental","pubTime":"2026-06-16 22:04","pubTimestamp":1781618646,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical  said Tuesday it presented new clinical data for its Voxzogo and BMN 333 treatments targeting hypochondroplasia and achondroplasia, both of which are growth-related bone conditions.An investigator-led Phase 2 extension study showed that Voxzogo led to sustained growth improvements in children with hypochondroplasia, the company said.The company intends to submit a supplemental New Drug Application to the US Food and Drug Administration during Q3 based on a separate Phase 3 study, it said.Initial Phase 1 testing of BMN 333 in healthy adults demonstrated prolonged drug exposure supporting a weekly dosing schedule for achondroplasia, BioMarin Pharmaceutical said.Patient enrollment for a Phase 2/3 study of the weekly drug began in April, with a data update from the dose-finding segment expected in 2027, the company added.Price: 55.13, Change: -0.52, Percent Change: -0.93","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","IE0002270589.USD","BMRN","BMN","BK4566","BK4139","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","BMRN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643504987","title":"BioMarin’s Voxzogo and BMN 333 show impact in hypochondroplasia, achondroplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2643504987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643504987?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:17","pubTimestamp":1781615869,"startTime":"0","endTime":"0","summary":"BioMarin (BMRN) Pharmaceutical announced new data from studies of Voxzogo – vosoritide – in children with hypochondroplasia and the investigational...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomarins-voxzogo-and-bmn-333-show-impact-in-hypochondroplasia-achondroplasia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomarins-voxzogo-and-bmn-333-show-impact-in-hypochondroplasia-achondroplasia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMN","IE0002270589.USD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BK4139","IE00B19Z3B42.SGD","BK4566","BMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642847448","title":"We're Hopeful That Bannerman Energy (ASX:BMN) Will Use Its Cash Wisely","url":"https://stock-news.laohu8.com/highlight/detail?id=2642847448","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642847448?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:05","pubTimestamp":1781121925,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052001-choice1-main-header/1585186931882","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052001-choice1-main-header/1585186931882"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/energy/asx-bmn/bannerman-energy-shares/news/were-hopeful-that-bannerman-energy-asxbmn-will-use-its-cash-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/energy/asx-bmn/bannerman-energy-shares/news/were-hopeful-that-bannerman-energy-asxbmn-will-use-its-cash-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BMN","BMN.AU","BK7083"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641408531","title":"Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2641408531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641408531?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:30","pubTimestamp":1780691400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nTUA1BXX5C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSTZ","MUJ","LU2264538146.SGD","BK4585","LU1291159041.SGD","BBN","BCX","BUI","ECAT","MUA","MYN","MHD","BOE","BST","MUC","MPA","BTT","LU0742537680.HKD","BMEZ","HYT","BTZ","BHV","MIY","BGR","BLK","LU0648001328.SGD","DSU","FRA","LU1481011911.USD","BIT","BCAT","CII","BMN","BLW","IE00B3PB1722.GBP","LU0980610538.SGD","LU1599440770.SGD","BKT","BHK","BK4533","BGY","BDJ","BGT","LU0157215616.USD","BTX","LU0772969993.USD","MQY","BME","LU0070302665.USD","LU2505996509.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167779215","title":"BioMarin's ENPP1 Deficiency Phase 3 Trial Falls Short, BMN 401 Fails to Meet Clinical Benefit Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1167779215","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167779215?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:50","pubTimestamp":1779119437,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical Inc. has released results from its pivotal Phase III ENERGY 3 trial for children aged 1 to 12 with ENPP1 deficiency. The drug achieved one co-primary endpoint: a statistically...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636079079","title":"BioMarin Pharmaceutical Reports No Functional Improvement in BMN 401 ENPP1 Deficiency Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2636079079","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636079079?lang=en_us&edition=fundamental","pubTime":"2026-05-18 21:50","pubTimestamp":1779112222,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical's  Phase 3 ENERGY 3 trial of BMN 401 in children with ENPP1 deficiency met one of two co-primary endpoints but did not show improvement in key clinical outcomes, the company said Monday.The study showed a statistically significant increase in plasma inorganic pyrophosphate levels but did not improve Radiographic Global Impression of Change scores, the primary measure of rickets severity.The company added that no notable trends were observed in secondary endpoints, and the therapy was generally well tolerated with no new safety concerns reported.Shares of BioMarin Pharmaceutical were down over 1% in Monday trading.Price: 51.27, Change: -0.55, Percent Change: -1.05","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","BMRN.AU","IE00B7SZLL34.SGD","BMN","IE00B19Z3B42.SGD","IE00B19Z3581.USD","IE0002270589.USD","BMRN","BK4566","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636772076","title":"BioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2636772076","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636772076?lang=en_us&edition=fundamental","pubTime":"2026-05-18 21:14","pubTimestamp":1779110092,"startTime":"0","endTime":"0","summary":"BioMarin (BMRN) announced results from the pivotal Phase 3 ENERGY 3 trial evaluating BMN 401 in children aged 1-12 with ENPP1 deficiency, a rare, s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomarins-bmn-401-meets-1-of-2-endpoints-in-phase-3-enpp1-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomarins-bmn-401-meets-1-of-2-endpoints-in-phase-3-enpp1-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002270589.USD","BMRN","BMN","BK4566","BK4139","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635443107","title":"BioMarin Extends BMN 351 Duchenne Study, Keeping Long-Term Data in Focus for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2635443107","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635443107?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:35","pubTimestamp":1778776540,"startTime":"0","endTime":"0","summary":"Biomarin Pharmaceutical Inc. ($BMRN) announced an update on their ongoing clinical study. BioMarin Pharmaceutical Inc. (BMRN) is running a follow-o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomarin-extends-bmn-351-duchenne-study-keeping-long-term-data-in-focus-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomarin-extends-bmn-351-duchenne-study-keeping-long-term-data-in-focus-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZLL34.SGD","BMN","BK4139","ISBC","IE0002270589.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4566","BMRN","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629057859","title":"BioMarin’s BMN 333 Takes On Vosoritide in High Stakes Achondroplasia Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2629057859","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629057859?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:34","pubTimestamp":1776962046,"startTime":"0","endTime":"0","summary":"Biomarin Pharmaceutical Inc. ($BMRN) announced an update on their ongoing clinical study. BioMarin Pharmaceutical Inc. (BMRN) is running a late sta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomarins-bmn-333-takes-on-vosoritide-in-high-stakes-achondroplasia-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomarins-bmn-333-takes-on-vosoritide-in-high-stakes-achondroplasia-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","BK4139","BMN","BMRN","IE0002270589.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628712507","title":"Controversy Surrounds BGN Procurement for MBG Project, From Motorbikes to EO Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2628712507","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628712507?lang=en_us&edition=fundamental","pubTime":"2026-04-20 11:53","pubTimestamp":1776657236,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-Indonesia’s National Nutrition Body  has come under public scrutiny over its procurement of goods and services, which many consider wasteful. The spending has also been seen as contradicting the core vision of the free nutritious meal program .Some of the highlighted procurements include the use of event organizer services, electric motorcycles, tableware, laptops, and tablets. Here are the explanations:","market":"nz","thumbnail":"https://statik.tempo.co/data/2026/03/31/id_1466649/1466649_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/03/31/id_1466649/1466649_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2099217/controversy-surrounds-bgn-procurement-for-mbg-project-from-motorbikes-to-eo-services","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2099217/controversy-surrounds-bgn-procurement-for-mbg-project-from-motorbikes-to-eo-services","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4139","SPPI","MBG.AU","BK7083","BMN.AU","BK7104","BMN","MBG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627476824","title":"Bannerman Energy Ltd (ASX:BMN) Is Expected To Breakeven In The Near Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2627476824","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627476824?lang=en_us&edition=fundamental","pubTime":"2026-04-15 08:56","pubTimestamp":1776214613,"startTime":"0","endTime":"0","summary":"Bannerman Energy Ltd ( ASX:BMN ) is possibly approaching a major achievement in its business, so we would like to shine...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052001-choice1-main-header/1585186931882","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052001-choice1-main-header/1585186931882"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/energy/asx-bmn/bannerman-energy-shares/news/bannerman-energy-ltd-asxbmn-is-expected-to-breakeven-in-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/energy/asx-bmn/bannerman-energy-shares/news/bannerman-energy-ltd-asxbmn-is-expected-to-breakeven-in-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BMN.AU","BMN","BK7083"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}